BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4770464)

  • 1. Transplantation of allogeneic tumours in rats treated with antilymphocyte serum.
    Kellen JA
    Oncology; 1973; 28(5):439-44. PubMed ID: 4770464
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic aspects of tumor induction by mammary tumor virus.
    Blair PB
    J Natl Cancer Inst; 1972 Apr; 48(4):1121-4. PubMed ID: 4336876
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 6. The histological response to a xenogeneic tumour in mice.
    Simpson E; Beverley PC
    Clin Exp Immunol; 1973 Jul; 14(3):443-55. PubMed ID: 4725398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of autochthonous grafts of spontaneous mammary tumor by induced allogeneic graft rejection mechanism.
    Tokuzen R; Nakahara W
    Cancer Res; 1973 Apr; 33(4):645-7. PubMed ID: 4696465
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.
    Haagensen DE; Roloson G; Collins JJ; Wells SA; Bolognesi DP; Hansen HJ
    J Natl Cancer Inst; 1978 Jan; 60(1):131-9. PubMed ID: 628013
    [No Abstract]   [Full Text] [Related]  

  • 9. The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with use of killed Bordetella pertussis.
    Likhite VV
    Cancer Res; 1974 May; 34(5):1027-30. PubMed ID: 4363061
    [No Abstract]   [Full Text] [Related]  

  • 10. Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition.
    Fisher B; Soliman O; Fisher ER
    Cancer Res; 1970 Jul; 30(7):2035-42. PubMed ID: 4917210
    [No Abstract]   [Full Text] [Related]  

  • 11. Antilymphocyte serum and allogeneic inhibition.
    Fisher B; Soliman O; Fisher ER
    Cancer Res; 1970 Jan; 30(1):66-8. PubMed ID: 5441081
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of x-irradiation and anti-lymphocyte serum on the responses to tumour allografts.
    Riches AC; Thomas DB
    Br J Cancer; 1970 Dec; 24(4):833-42. PubMed ID: 5503605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth of tumour allografts as a measure of the immunosuppressive potency of antilymphocyte sera.
    Riches AC; Thomas DB
    Experientia; 1972 Jun; 28(6):694-6. PubMed ID: 4558088
    [No Abstract]   [Full Text] [Related]  

  • 14. Allograft reaction against H-2-region antigens.
    Klein J
    Transplant Proc; 1977 Mar; 9(1):847-52. PubMed ID: 17202
    [No Abstract]   [Full Text] [Related]  

  • 15. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV
    Int J Cancer; 1974 Nov; 14(5):684-90. PubMed ID: 4459281
    [No Abstract]   [Full Text] [Related]  

  • 16. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 18. Rejection of mammary adenocarcinoma cell tumors and the prevention of progressive growth of incipient metastases following intratumor permeation with killed Bordetella pertussis.
    Likhite VV
    Cancer Res; 1974 Oct; 34(10):2790-4. PubMed ID: 4370327
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenocarcinoma associated antigen: enhancement of tumor growth with serum from animals bearing adenocarcinoma.
    Hakin AA
    Surg Forum; 1975; 26():175-7. PubMed ID: 1216104
    [No Abstract]   [Full Text] [Related]  

  • 20. Rejection of murine mammary tumours in BALB/c mice.
    Robidoux S; Kajdos A; Tomana M; Niedermeier CW
    Br J Cancer; 1979 Jan; 39(1):99-100. PubMed ID: 758934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.